Please login to the form below

Not currently logged in
Email:
Password:

EMA’s head of human medicines development steps down

Patrick Le Courtois leaves regulator after 16 years

EMA Patrick Le CourtoisThe European Medicines Agency (EMA) has announced that Dr Patrick Le Courtois is to retire as head of human medicines development and evaluation.

Dr Le Courtois (pictured right) will leave the regulatory body later this month after 16 years at the EMA, having joined in 1997 as human medicinal products head of unit support.

He then served as head of new chemical substance and head of scientific advice and orphan drugs before being appointed to the regulator's senior management team in 2001 when he became head of pre-authorisation evaluation of medicines for human use. He has been in his current position since 2009.

"Patrick's retirement brings to a close a remarkable career of 16 years of service to the Agency,” said Guido Rasi, executive director of the EMA.

“I would like to formally thank Patrick for his innumerable contributions to public health and for his resolute commitment to helping build a strong European medicines system.”

Prior to joining the EMA, Dr Le Courtois was head of oncology, anti-infectives and coordination of European Procedures at the regulatory agency for France having spent several years in the country's ministry of health.

The EMA did not say if a successor was lined up to replace Dr Le Courtois.

2nd August 2013

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics